↓ Skip to main content

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

Overview of attention for article published in Diabetologia, September 2009
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
49 Mendeley
citeulike
1 CiteULike
Title
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Published in
Diabetologia, September 2009
DOI 10.1007/s00125-009-1530-5
Pubmed ID
Authors

Home PD, Lagarenne P, P. D. Home, P. Lagarenne

Abstract

Recent publications of data extracted from population registries have suggested a possible relationship between treatment with insulin glargine and increased incidence of cancer/breast cancer. The aim of the present study was investigate this possible relationship using data from the manufacturer's (sanofi-aventis) pharmacovigilance database.

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
France 1 2%
Italy 1 2%
United Kingdom 1 2%
Mexico 1 2%
Brazil 1 2%
Japan 1 2%
Unknown 42 86%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 24%
Student > Master 11 22%
Student > Bachelor 5 10%
Other 5 10%
Student > Ph. D. Student 4 8%
Other 12 24%
Readers by discipline Count As %
Medicine and Dentistry 32 65%
Agricultural and Biological Sciences 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Unspecified 2 4%
Computer Science 2 4%
Other 4 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2010.
All research outputs
#2,016,306
of 3,622,349 outputs
Outputs from Diabetologia
#665
of 1,130 outputs
Outputs of similar age
#100,585
of 231,768 outputs
Outputs of similar age from Diabetologia
#15
of 38 outputs
Altmetric has tracked 3,622,349 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,130 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,768 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.